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Abstract  
Ciprofloxacin, CFL is a drug that belongs to the second generation 
of fluoroquinolone antibiotics with a wide range of effects on 
Gram-positive and Gram-negative bacteria. The aim of this work 
was to investigate the interaction of CFL as ligand with divalent 
biological cations (Mn2+, Ni2+ and Co2+) in approximate 
physiological conditions. Synthesized complexes were 
characterized using FTIR and stereo-microscopy. Antimicrobial 
screening was performed on bacterial strains of Escherichia coli, 
Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus 
aureus.  
The results of FTIR spectroscopy showed that the M(II) complexes 
with CFL were formed through the oxygen donors of the carboxyl 
and carbonyl group of the ligand. Stereo-microscopic 
characterization revealed the difference in color and size of 
crystals of the ligand and metal complexes. Antimicrobial 
screening has shown that CFL and complexes have almost similar 
antimicrobial activity against investigated bacterial strains. 
 
 
 
1. INTRODUCTION 
Ciprofloxacin (CFL) is a synthetic antibacterial 
fluoroquinolone related to nalidixic acid having a 
fluorine atom and piperazine ring at the positions 6 
and 7 of quinolone-3-carboxylic acid (Nagalapalli 
and YagaBheem, 2014). It is a broad-spectrum 
antibiotic, sensitive to gram-negative and more 
effective against gram-positive bacteria, including 
Staphylococcus aureus, Streptococcus pneumoniae 
and Enterococcus faecalis (Ali et al., 2010). It is 
used intravenously in the form of lactate salts (Al-
Omar, 2005). The structure of ciprofloxacin is 
shown in Figure 1. Ciprofloxacin, first introduced in 
1987, is one of the most widely used 
fluoroquinolones now (Choi et al., 2013). According 
to the World Health Organization, CFL is one of the 
most frequently prescribed antimicrobial drugs 
(Correia et al., 2017). CFL impedes the replication 
and transcription of bacterial DNA, leading to an 
increase in oxidative stress and death of bacterial 
cells (Masadeh et al, 2016). 
 
Figure 1. Structure of CFL 
CFL is the most effective quinolone against 
Pseudomonas aeruginosa (Lebel, 1988). It is 
applied in the treatment of infections of the lower 
respiratory tract, skin, soft tissue, sexually 
transmitted diseases, and urinary tract infections 
(Fàbrega et al, 2009). CFL is the first 
fluoroquinolone, which has shown significant 
activity outside the urinary tract. Quinolones realize 
their effect by converting gyrases and 
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topoisomerases IV into toxic enzymes that fragment 
bacterial chromosome (Aldred et al., 2014). CFL,  
 
like other quinolones, inhibits DNA gyrase, but its 
bacteriological effects are not completely reversible. 
Therefore, unlike many other quinolones, 
ciprofloxacin may have multiple lethal effects 
(Sanders, 1988). CFL has been observed that it can 
induce inhibition of growth, depending on time and 
dose, and apoptosis of various carcinoma, 
osteosarcoma and others. (Sharma et al., 2010). It 
induces S-phase arrest and augment apoptotic 
effects of cisplatin in human pancreatic cancer cells 
(Yadav et al., 2015). This drug is partially 
metabolized in the liver by modifying the piperazinyl 
group to at least four metabolites. These 
metabolites, identified as desethyleneciprofloxacin, 
sulfo-ciprofloxacin, oxo-ciprofloxacin and N-acetyl 
ciprofloxacin, exhibit weaker microbiological activity 
than the starting form of the drug, but similar or 
stronger activity relative to some other quinolones 
(Al-Omar, 2005). Serum concentrations of 
metabolite are less than 10% of CFL levels, even in 
reduced renal function (Bergan et al, 1989). Various 
compounds are introduced into the body by food or 
drugs, which may potentially interact with metals 
and thereby affecting their biological effect 
(Cipurković et al., 2017). Metal complexes stay a 
significant resource for creating chemical diversity 
in the fields of biological, pharmaceutical and 
medicinal chemistry as antitumor and antimicrobial 
agents (Ljubijankić et al., 2018). Analysis of the 
interaction of biological M(II) ions with O, N and S-
donor atoms of ligands, often used in the treatment 
of a wide spectrum of diseases, is important for 
pharmacokinetics, monitoring distribution, 
excretion, drug efficacy and monitoring adverse 
effects (Cipurković et al., 2017). Input and 
transport of manganese (Mn) ions are important for 
all organisms. Mn plays an important role in the 
metabolism of lipids, proteins and carbohydrates 
(Porcheron et al., 2013). Its absorption in the 
gastrointestinal tract takes place in a divalent and 
tetravalent form (Barceloux D. G. and Barceloux D., 
1999). Cobalt (Co) is a core element of vitamin B12 
(cyanocobalamin), which is essential for the 
prevention of anemia in humans (Huwait et al., 
2015). Co is thought to enhance erythropoietin 
expression by replacing the essential Fe2+ in the 
HIF-α dioxygenases (Jelkmann, 2011). Co is found 
in human organisms in the amounts of 1 to 2 mg 
(Cezarnek et al, 2015). Nickel (Ni) is functional 
microelement for the activity of urease enzymes (). 
Ni facilitates the absorption of iron (Fe3+) in the 
intestines, and it is also cofactor in metalloenzymes 
and metalloproteins (Samal and Mishra, 2011). Ni is 
necessary for the biosynthesis of hydrogenase, 
carbon monoxide dehydrogenase. It is found in a 
large number of bacteria (Can et al, 2014). Nickel 
can influence human health through infectious 
diseases caused by nickel-dependent bacteria 
(Zambelli et al, 2013). This bio element and its 
compounds are well known as carcinogens (Oller, 
2002). However, the identity of these compounds, 
which increase the risk of cancer, is still unclear 
(Barceloux D.G. and Barceloux D., 1999). The aim 
of this paper is to examine the interaction of some 
biological essential transition metal ions with CFL in 
model systems in approximately physiological 
conditions.  
2. MATERIAL AND METHODS 
2.1. Synthesis of complex 
 
A mixture of ethanol and water, in a ratio of 50/50 
(v/v), was used as a solvent for ligand and M(II) 
salts. Metals (M) and ligand (L) were mixed in a 1:2 
molar ratio (n/n). The solutions of the appropriate 
metal (10 mL) and ligand (10 mL) were mixed in a 
glass and stirred on a magnetic stirrer, without 
heating. pH value of solutions were adjusted with 
1M NaOH. The optimum pH value for all model 
systems was 7.3. Prepared solutions were mixed in 
magnetic stirrer for half an hour and then left to 
stand in a darkened area for two weeks in order to 
precipitate complexes. The resulting products were 
filtered through a blue strip filter paper and then 
dried at room temperature. Characterizations of 
obtained products were performed as earlier 
described (Cipurković et al., 2017). 
2.2. FTIR characterization 
 
In order to determine structure of the complex, 
samples were recorded on Nicolet iS10 FT-IR 
spectrophotometer - Thermo Fisher Scientific. 
2.3. Morphological characterization 
 
Before morphological characterization, solid 
complexes were treated with DMSO. Microscopic 
analysis were performed in order to compare color, 
texture, ligand particle size. Shots were performed 
on the binocular microscope, the Leica DM 2500P 
mark. Samples were recorded in polarized light, 
with and without crossed Nicole (XPL and PPL).  
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2.4. In vitro antimicrobial activity 
 
Antimicrobial activity was investigated by diffusion 
method on reference bacterial strains (from ATCC 
collection) from gram positive (Staphylococcus 
aureus ATCC 25923 and Enterococcus faecalis ATCC 
51299) and gram-negative bacteria (Escherichia coli 
ATCC 25922 and Salmonella Enteritidis ATCC 
13076). From the bacterial strains of overnight 
cultures, suspensions of 0.5 McFarland turbidity 
were prepared (density 107-108 CFU/mL, 
depending on soy). The strains were then placed on 
the surface of the nutrient substrate-Mueller-Hinton 
agar (MH), dispersed in sterile Petri dishes. 
Substrate thickness was 4 mm. In the agar sterile 
drill-shaped holes were made ("wells"), into which 
50 μL of CFL and different M(II) complexes 
solutions in concentration of 1 mg/ml were added. 
After the plates were left at room temperature for 
15 minutes, the substance was diffused into agar, 
incubated at 37⁰C/24 h. After the incubation period, 
the size of the inhibitory zone was measured and 
the sensitivity of the microorganisms was expressed 
as follows: if the zone for inhibition of 
microorganism growth was greater than 20 mm, it 
was labeled with three pluses (+++), representing 
the highest sensitivity of the microorganisms. If the 
inhibitory zone ranged from 16 to 20 mm, it was 
marked with two pluses (++). Very weak sensitivity 
is marked with a plus (+) if the inhibitory zone is 
10-15 mm in diameter. For the inhibitory zone less 
than 10 mm or if absent, the minus (-) has been 
used (Pirvu et al., 2014).  
3. RESULTS AND DISCUSSION 
3.1. Structure of the complex 
 
The proposed structure of CFL complexes with 
metal ions (Mn2+, Co2+ or Ni2+) is shown in Figure 2. 
 
Figure 2. Structure of ML2 complex  
(M = Co2+, Ni2+, Mn2+, L = CFL) 
Taking into account the molar ratio of the reactants, 
as well as the obtained FTIR spectra for the 
synthesized complexes, we conclude that CFL 
coordinates metal ions as bidentate O donor ligand 
in molar ratio of CFL:M = 2:1. One oxygen atom of 
ligand carbonyl group and one oxygen atom from 
the deprotonated -COOH group are involved in 
chemical bonds with M(II) ions, forming the 
octahedral complex. Similar research was 
performed by other scientists (Chohan et al., 2005). 
According to their results, two molecules of water 
are also coordinated on metal ion. The obtained 
complexes differ in color from the parent ligand. 
The complex Co(CFL)2(H2O)2 is light pink, 
Mn(CFL)2(H2O)2 is light brown and Ni(CFL)2(H2O)2 is 
light green. 
3.2. FTIR characterization 
 
Figure 3 shows FTIR spectra of ligands and obtained 
complexes.  
 
Figure 3. FTIR spectra of CFL and metal complexes 
Characteristic bands for ligand and synthesized 
complexes are presented in Table 1. There are two 
very strong absorption bands in the spectrum of 
CFL at 1705,6 and 1624 cm-1 assigned to νCOOH 
and νC=O stretching vibrations. On comparison of 
these IR frequencies, these bands completely 
vanished in the spectra of the metal complexes. 
Instead, the strong absorption bands positioned at 
1571–1572,3 and 1372–1375,6 cm-1 indicating that 
νCOOH group emerged as two absorption bands 
νasymmet COO and νsymmetCOO and its coordination 
with the metal atoms. Similarly, the band at 1624 
cm-1 due to the C=O moiety in the spectrum of the 
drug ligand disappeared and instead a new band at 
10–15 cm-1 lower frequency (~1610 cm-1) appeared 
indicating involvement of the carbonyl group in 
coordination. On the basis of these changes we can 
propose that the drug ligand, CFL is acting as 
bidentate O-donor. 
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Table 1. Selected FTIR spectral vibrations of CFL    
and its metal complexes (cm-1) 
 
Group CFL M(CFL)2(H2O)2 
Ni2+ Mn2+ Co2+ 
O-H 
(COOH) 
3529 - - - 
N-H 3373 3342 3347 3356 
C=O 1624 1613 1611 1611 
C=O 
(COOH) 
1705 - - - 
C-O 1022 1030 1026 1026 
C-F 1267 1252 1250 1249 
C-N 1307 1307 1307 1303 
3.3. Morphological characterization 
 
The morphologies of CFL crystals and its complexes 
with Co2+, Ni2+ and Mn2+ are presented in Figure 4. 
Crystals of CFL (Figures A-1 and A-2) are of small 
(below 1 mm) and medium size (1-10 mm). 
Interferential colors are alive and of first order. 
These crystals appear radially airy coming from a 
common center (Figure A-1) or have prismatic 
forms (Figure A-2). The similarity of the crystalline 
forms can be seen between CFL and the complex 
Ni(CFL)2(H2O)2 (Figures D-1 and D-2) with radially 
airy structure of crystals. Crystals of radial forms of 
Ni(II) complex are significantly smaller then CFL 
crystals (almost 40%). These crystals have 
prismatic forms, which size is about 0.1 mm (Figure 
D-2). Unlike the crystals in Figure A-2, these are 
significantly smaller and do not have lammels. 
Complexes of Co(II) (Figure B-1 and B-2) and 
Mn(II) (Figures C-1 and C-2) do not develope 
crystals after treatment with DMSO.  
 
 
Figure 4. Morphology of (A) CFL crystals, (B) 
Co(CFL)2(H2O)2 crystals, (C) Mn(CFL)2(H2O)2 
crystals and (D) Ni(CFL)2(H2O)2 crystals 
The samples of these crystals are very small (so-
called microliths, sizes below 0.02 mm) with 
irregular (polygonal) forms. Due to the coagulation, 
polarized light could not pass through these 
samples, so black or dark brown aggregates, 
thickness over 0.03 mm, were obtained. 
3.4. Antimicrobial activity in vitro 
 
Results of the in vitro antimicrobial activity of 
synthesized complexes against selected bacterial 
strains are shown in Table 2.  
Table 2. Antimicrobial activities of CFL and its 
complexes M(CFL)2(H2O)2 
 
Ligand/Complexes Inhibition zone [mm] 
Escherichia coli (ATCC 25922) 
CFL 40 
Mn(CFL)2(H2O)2 35 
Co(CFL)2(H2O)2 42 
Ni(CFL)2(H2O)2 36 
Staphylococcus aureus (ATCC 25923) 
CFL 35 
Mn(CFL)2(H2O)2 35 
Co(CFL)2(H2O)2 35 
Ni(CFL)2(H2O)2 33 
SalmonellaEnteritidis (ATCC 13076) 
CFL 39 
Mn(CFL)2(H2O)2 38 
Co(CFL)2(H2O)2 36 
Ni(CFL)2(H2O)2 35 
Enterococcus faecalis (ATCC 51299) 
CFL 27 
Mn(CFL)2(H2O)2 30 
Co(CFL)2(H2O)2 28 
Ni(CFL)2(H2O)2 25 
 
In the case of E. coli, the inhibitory activity ranges 
from 35 mm (for Mn(CFL)2(H2O)2) to 42 mm (for 
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Co(CFL)2(H2O)2). Inhibition zone for S. aureus is 
almost the same, while for Salmonella Enteritidis 
was observed less antimicrobial activity of the 
complex than for antibiotic (CFL >Mn(CFL)2(H2O)2 > 
Co(CFL)2(H2O)2 > Ni(CFL)2(H2O)2). In the case of E. 
faecalis, antimicrobial activity of complexes is 
greater than to the parent ligand (except for 
Ni(CFL)2(H2O)2). In comparison with the results 
obtained by Chohan and al. (2005), different values 
of antimicrobial activities for bacterial strains of E. 
coli and S. aureus are observed. The inhibition 
zones that they published for these strains are less 
than the results we obtained. In both cases, 
analyzes were performed for CFL and its complexes 
concentrations of 1 mg/mL, but different sample 
volumes were used (they used 100 μL, which is 
twice more than the volumes we used). However, 
there is a difference in the larger inhibitory zones of 
some M(II) complexes compared with parent 
antibiotic. In the results published by Chohan and 
al, all complexes have greater antimicrobial 
activities than CFL. For many chelates of quinolones 
obtained in solid state, an equal, lower or superior 
biological activity was observed compared to that of 
parent drugs. The consequence of interaction with 
metal ions on the biological activity of quinolones 
was approached as a negative phenomenon, 
bringing to reduction in the antimicrobial activity of 
quinolones in the presence of metal ions. The 
reduction of CFL activity by metal cations could be 
explained as the formation of an inactive chelate or 
decreased permeation of the antibiotic into bacterial 
cells (Ma et al., 1997).  From the other side, 
increased biological activity of metal chelates can be 
explained by the concept of chelation theory and 
cell permeability. Delocalization of pi  electrons over 
the whole chelate ring increases the lipophilic 
nature of the central ion which enhances the 
passage of complex through the lipid membranes 
and the penetration in cells (Tumer et al., 1999; 
Imran et al., 2007; Patel et al., 2007). 
4. CONCLUSION 
Metal ions are known to affect the action of many 
drugs structure quinolones. In this paper we have 
studied interaction of some biometal ions with CFL 
in water/ethanol solution. According to the obtained 
FTIR spectra, it is confirmed that CFL as ligand co-
ordinate as bidentate ligand through one of the 
oxygen atoms of the deprotonated carboxyl group 
and the ring carbonyl atom.  Synthesized 
complexes are not structurally different from similar 
complexes that were published by other scientists 
earlier. It is proposed that Co2+, Ni2+ and Mn2+ions 
form with CFL the octahedral complex in 
approximately physiological conditions. Based on 
morphological data, it has been determined that 
forms of CFL crystals are radially airborne and 
prismatic. Morphological similarity of Ni(II) complex 
with CFL was observed, unlike the complexes of 
Mn(II) and Co(II) with CFL. The antimicrobial 
activities of M(CFL)2(H2O)2 were performed on four 
bacterial strains and compared with the activity of 
parent ligand. Antimicrobial activities were 
decreased for complexes with regard to the parent 
ligand, except in the case of Co(CFL)2(H2O)2 
complex activity on E. coli and Mn(CFL)2(H2O)2 and 
Co(CFL)2(H2O)2 complexes activities on E. faecalis.  
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